|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: [email protected]. Type 508 Accommodation and the title of the report in the subject line of e-mail. Notice to Readers Alcohol and Other Drug-Related Birth Defects Awareness Week, May 12-18, 1996The National Council on Alcoholism and Drug Dependence (NCADD) has designated May 12-18, 1996, as Alcohol and Other Drug-Related Birth Defects Awareness Week. One of the leading causes of birth defects in the United States is fetal alcohol syndrome (FAS), which results from in utero alcohol exposure. In the United States each year, an estimated 12,000 children are born with FAS (1). The prevalence of FAS ranges from 0.7 cases per 1000 live births for the total U.S. population to 2.7 for American Indians/Alaskan Natives (2-4). A congressionally mandated report prepared by the Institute of Medicine (IOM) indicated that, although the overall prevalence of any reported alcohol use during pregnancy has declined since the mid-1980s, the proportion of women who drink heavily during pregnancy has remained constant (1). However, a recent study documented that a high proportion of women with certain characteristics (i.e., nonwhite, smoker, low income, and no prenatal care) are more likely to consume more than six drinks per week during their last pregnancy (5). The IOM report recommended the creation of a interagency task force to facilitate research directed toward 1) estimating the true prevalence of FAS and of alcohol use among pregnant and reproductive-aged women; 2) improving understanding of the risk factors for drinking heavily during pregnancy; and 3) developing a model for preventing drinking during pregnancy, which includes the participation of the woman's partner, family members, and health-care providers. CDC-sponsored prevention projects being evaluated include prenatal interventions for pregnant women who report alcohol use and reproductive-health education and counseling for women in drug- and alcohol-treatment centers. Additional information about Alcohol and Other Drug-Related Birth Defects Awareness Week is available from NCADD, 12 West 21 Street, New York, NY 10010; telephone (212) 206-6770. Copies of the IOM executive summary are available free of charge from the Institute of Medicine, 2101 Constitution Avenue, NW, Washington, DC, 20418. References
Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to [email protected].Page converted: 09/19/98 |
|||||||||
This page last reviewed 5/2/01
|